AlveoliX AG develops organs-on-chip technologies and provides modular systems and biomodels for in vitro testing and preclinical research. Its portfolio includes the AX Barrier-on-Chip and AX Lung-on-Chip systems, the AX12 platform, and services for developing custom biomodels and running safety, efficacy and toxicity assays.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Bioengineered in vitro models that mimic the structure and function of human organs, enabling simulation of human physiology, drug discovery and reduction of animal testing.
AX Lung-on-Chip System
Lung-on-chip system for dynamic breathing experiments, advanced lung in-vitro models, drug discovery and preclinical studies; includes AX12, AXDock, AXExchanger and AXBreather.
AX Barrier-on-Chip System
Barrier-on-chip system for modelling tissue barriers with 3D stretch, customizable motion patterns, TEER measurements and compatibility with standard laboratory equipment.
AX Biomodels
In vitro biomodels for toxicity and efficacy testing, including monoculture, co-culture, immuno, inflammation, fibrosis and custom models transferred to the customer’s lab.
Custom Models
Design, development and transfer of new organs-on-chip models, established and tested by the team before support is provided in the customer’s lab.
Knowledge
No knowledge articles yet
Once AlveoliX AG has claimed this profile, we'll publish editorial articles and case studies here together.